Evidence map›Paper›PMID 42652929›Full record

ArticleLife (Basel, Switzerland)2026

Integrated Chemical Profiling and Network Pharmacology Establish a Quality Evaluation Framework for the Four Medicinal Parts of

Shun-Xin Deng, Lih-Geeng Chen, Shih-Yi Hsiung, Vinh Tuyen T Le, Chia-Jung Lee, Yves S Y Hsieh, Ching-Chiung Wang

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shun-Xin DengPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Lih-Geeng ChenDepartment of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences, National Chiayi University, Chiayi 600355, Taiwan.ORCID 0000-0003-2407-6782
Shih-Yi HsiungSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0003-0363-5987
Vinh Tuyen T LePh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Chia-Jung LeePh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-9416-5468
Yves S Y HsiehPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Ching-Chiung WangPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan.

Funding

Ministry of Science and Technology of Taiwan MOST107-2320-B-038-024-MY3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemometric analysisL* valuesmonosaccharidesneuroprotectionPA/PABquality controltriterpenoidsWolfiporia extensa (WE)

Identifiers

PMID42652929
PMCPMC13514367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.